Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile

被引:158
作者
Devaraj, S
Vega-López, S
Kaul, N
Schönlau, F
Rohdewald, P
Jialal, I
机构
[1] Univ Calif Davis, Lab Atherosclerosis & Metab Res, Ctr Med, Sacramento, CA 95817 USA
[2] Univ Munster, Inst Pharmaceut Chem, D-4400 Munster, Germany
关键词
D O I
10.1007/s11745-006-0982-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Pycnogenol((R)) (PYC), an extract of French maritime pine bark (Pinus pinaster), is a potent antioxidant with potential health benefits. Its bioavailabilty has previously been shown by urinary excretion studies of constituents and metabolites of PYC. The aim of this study was to test the effect of PYC supplementation on measures of oxidative stress and the lipid profile in humans. Twenty-five healthy subjects received PYC (150 mg/d) for 6 wk. Fasting blood was collected at baseline, after 3 and 6 wk of supplementation, and again after a 4-wk washout period. After 6 wk of supplementation with PYC, a significant increase in plasma polyphenol levels was detectable, which was reversed after the 4-wk washout phase. The antioxidant effect of PYC was demonstrated by a significant increase in oxygen radical absorbance capacity (ORAC) in plasma throughout the supplementation period (P < 0.05). The ORAC value returned to baseline after the 4-wk washout period. Moreover, in addition to its antioxidant effects, PYC significantly reduced LDL-cholesterol levels and increased HDL-cholesterol levels in plasma of two-thirds of the subjects. While the LDL changes reversed during washout, the HDL increase did not. There was no significant difference in LDL oxidizability or plasma lipid peroxides following PYC supplementation. Hence, following oral supplementation in humans, PYC significantly increases antioxidant capacity of plasma, as determined by ORAC, and exerts favorable effects on the lipid profile.
引用
收藏
页码:931 / 934
页数:4
相关论文
共 29 条
[1]
OXIDANTS, ANTIOXIDANTS, AND THE DEGENERATIVE DISEASES OF AGING [J].
AMES, BN ;
SHIGENAGA, MK ;
HAGEN, TM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (17) :7915-7922
[2]
[Anonymous], 1999, EUROPEAN B DRUG RES
[3]
Cao GH, 1999, METHOD ENZYMOL, V299, P50
[4]
In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue [J].
Chida, M ;
Suzuki, K ;
Nakanishi-Ueda, T ;
Ueda, T ;
Yasuhara, H ;
Koide, R ;
Armstrong, D .
OPHTHALMIC RESEARCH, 1999, 31 (06) :407-415
[5]
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]
Cossins E, 1998, BIOCHEM MOL BIOL INT, V45, P583
[7]
ANTIOXIDANTS AND AGING [J].
CUTLER, RG .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (01) :S373-S379
[8]
Düweler KG, 2000, PHARMAZIE, V55, P364
[9]
FREE-RADICALS IN BRAIN METABOLISM AND PATHOLOGY [J].
EVANS, PH .
BRITISH MEDICAL BULLETIN, 1993, 49 (03) :577-587
[10]
Redox regulation of NF-kappa B activation [J].
Flohe, L ;
Brigelius-Flohe, R ;
Saliou, C ;
Traber, MG ;
Packer, L .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (06) :1115-1126